Literature DB >> 36253043

Quantifying antibiotic use in typhoid fever in India: a cross-sectional analysis of private sector medical audit data, 2013-2015.

Shaffi Fazaludeen Koya1, Habib Hasan Farooqui2, Aashna Mehta3, Sakthivel Selvaraj3, Sandro Galea4.   

Abstract

OBJECTIVES: To estimate the antibiotic prescription rates for typhoid in India.
DESIGN: Cross-sectional study.
SETTING: Private sector primary care clinicians in India. PARTICIPANTS: The data came from prescriptions of a panel of 4600 private sector primary care clinicians selected through a multistage stratified random sampling accounting for the region, specialty type and patient turnover. The data had 671 million prescriptions for antibiotics extracted from the IQVIA database for the years 2013, 2014 and 2015. PRIMARY AND SECONDARY OUTCOME MEASURES: Mean annual antibiotic prescription rates; sex-specific and age-specific prescription rates; distribution of antibiotic class.
RESULTS: There were 8.98 million antibiotic prescriptions per year for typhoid, accounting for 714 prescriptions per 100 000 population. Children 10-19 years of age represented 18.6% of the total burden in the country in absolute numbers, 20-29 year age group had the highest age-specific rate, and males had a higher average rate (844/100 000) compared with females (627/100 000). Ten different antibiotics accounted for 72.4% of all prescriptions. Cefixime-ofloxacin combination was the preferred drug of choice for typhoid across all regions except the south. Combination antibiotics are the preferred choice of prescribers for adult patients, while cephalosporins are the preferred choice for children and young age. Quinolones were prescribed as monotherapy in 23.0% of cases.
CONCLUSIONS: Nationally representative private sector antibiotic prescription data during 2013-2015 indicate a higher disease burden of typhoid in India than previously estimated. The total prescription rate shows a declining trend. Young adult patients account for close to one-third of the cases and children less than 10 years account for more than a million cases annually. © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  EPIDEMIOLOGY; INFECTIOUS DISEASES; PUBLIC HEALTH

Mesh:

Substances:

Year:  2022        PMID: 36253043      PMCID: PMC9577907          DOI: 10.1136/bmjopen-2022-062401

Source DB:  PubMed          Journal:  BMJ Open        ISSN: 2044-6055            Impact factor:   3.006


  33 in total

Review 1.  Assuring health coverage for all in India.

Authors:  Vikram Patel; Rachana Parikh; Sunil Nandraj; Priya Balasubramaniam; Kavita Narayan; Vinod K Paul; A K Shiva Kumar; Mirai Chatterjee; K Srinath Reddy
Journal:  Lancet       Date:  2015-12-12       Impact factor: 79.321

2.  The cost-effectiveness of typhoid Vi vaccination programs: calculations for four urban sites in four Asian countries.

Authors:  Joseph Cook; Marc Jeuland; Dale Whittington; Christine Poulos; John Clemens; Dipika Sur; Dang Duc Anh; Magdarina Agtini; Zulfiqar Bhutta
Journal:  Vaccine       Date:  2008-10-07       Impact factor: 3.641

3.  The malaria and typhoid fever burden in the slums of Kolkata, India: data from a prospective community-based study.

Authors:  Dipika Sur; Lorenz von Seidlein; Byomkesh Manna; Shanta Dutta; Alok K Deb; Banwari Lal Sarkar; Suman Kanungo; Jacqueline L Deen; Mohammad Ali; Deok Ryun Kim; Vinay Kumar Gupta; R Leon Ochiai; Ataru Tsuzuki; Camilo J Acosta; John D Clemens; Sujit K Bhattacharya
Journal:  Trans R Soc Trop Med Hyg       Date:  2006-01-18       Impact factor: 2.184

4.  Reduced burden of childhood diarrheal diseases through increased access to water and sanitation in India: A modeling analysis.

Authors:  Arindam Nandi; Itamar Megiddo; Ashvin Ashok; Amit Verma; Ramanan Laxminarayan
Journal:  Soc Sci Med       Date:  2016-08-31       Impact factor: 4.634

5.  Antibiotic Resistance and Typhoid.

Authors:  Zoe A Dyson; Elizabeth J Klemm; Sophie Palmer; Gordon Dougan
Journal:  Clin Infect Dis       Date:  2019-03-07       Impact factor: 9.079

6.  Tuberculosis treatment in the private healthcare sector in India: an analysis of recent trends and volumes using drug sales data.

Authors:  Nimalan Arinaminpathy; Deepak Batra; Nilesh Maheshwari; Kishan Swaroop; Lokesh Sharma; Kuldeep Singh Sachdeva; Sunil Khaparde; Raghuram Rao; Devesh Gupta; Bhavin Vadera; Sreenivas A Nair; Kiran Rade; Sameer Kumta; Puneet Dewan
Journal:  BMC Infect Dis       Date:  2019-06-19       Impact factor: 3.090

Review 7.  Typhoid fever: Control & challenges in India.

Authors:  Bratati Mukhopadhyay; Dipika Sur; Sanjukta Sen Gupta; N K Ganguly
Journal:  Indian J Med Res       Date:  2019-11       Impact factor: 2.375

8.  Longitudinal Typhoid Fever Trends in India from 2000 to 2015.

Authors:  Veeraraghavan Balaji; Arti Kapil; Jayanthi Shastri; Agila Kumari Pragasam; Geeta Gole; Sirshendu Choudhari; Gagandeep Kang; Jacob John
Journal:  Am J Trop Med Hyg       Date:  2018-07-24       Impact factor: 2.345

9.  The Control of Typhoid Fever in Vietnam.

Authors:  Tran Vu Thieu Nga; Pham Thanh Duy; Nguyen Phu Huong Lan; Nguyen Van Vinh Chau; Stephen Baker
Journal:  Am J Trop Med Hyg       Date:  2018-07-24       Impact factor: 2.345

10.  The number of privately treated tuberculosis cases in India: an estimation from drug sales data.

Authors:  Nimalan Arinaminpathy; Deepak Batra; Sunil Khaparde; Thongsuanmung Vualnam; Nilesh Maheshwari; Lokesh Sharma; Sreenivas A Nair; Puneet Dewan
Journal:  Lancet Infect Dis       Date:  2016-08-25       Impact factor: 25.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.